Roundup at a Crossroads: Bayer Lays Out Short-Term Window for Finding a Way Forward with Glyphosate Per CEO Bill Anderson in an interview this week, Bayer will have a decision in months — not ...

European pharma stocks decline as Trump reiterates tariff plans Bayer petitions U.S. Supreme Court to review Roundup case Bayer is said to consider ending production of Roundup amid legal costs ...

Bayer is making another push to resolve lawsuits linking the popular weedkiller Roundup to cancer, while exploring a bankruptcy filing for its Monsanto agriculture business in case the settlement ...

Bayer AG has won its fifth consecutive trial over claims that its weedkiller Roundup causes cancer, the company announced Thursday.

Bayer BAYN -1.16% faces a payout of $1.56 billion after a Missouri jury found in favor of the plaintiffs who blamed its Roundup weedkiller for causing their cancers.

Bayer AG saw its shares soar by 10% in early German trading following a crucial legal victory concerning its Roundup weedkiller. The surge came after a Philadelphia appeals court ruled in favor of ...

Under head coach Xabi Alonso, Bayer Leverkusen have won the Bundesliga and are on the cusp of winning the DFB-Pokal and Europa League — and of completing that treble unbeaten. This could be one ...

Bayer was ordered to pay $1.56 billion to four plaintiffs -- three of which alleged that using Roundup caused their non-Hodgkin lymphoma diagnosis.

Bayer's Louisiana glyphosate plant is back online, but the glyphosate shortage is industry wide as one Extension weed scientist says growers need to make multiple crop chemistry plans for the next ...

Vanessa Bayer refused to tell her family that she was joining the cast of “Saturday Night Live” until an official announcement was made by NBC.

Bayer Leverkusen have become the first team to go through a whole Bundesliga season unbeaten after defeating Augsburg 2-1 on Saturday. Xabi Alonso’s side clinched their 28th win of the ...

Bayer AG dropped the most in its history, losing about €7.6 billion ($8.3 billion) in market value, after suffering major courtroom and drug-development setbacks that raise pressure on its new ...